Exosomal miR-25 from Mesenchymal Stem Cells Reduces T Cell Migration and Eases Type 1 Diabetes via CXCR3 Targeting
Research explores the role of mesenchymal stem cell (MSC)-derived exosomes in modulating immune responses in Type 1 diabetes mellitus (T1DM). Findings indicate that exosomal miR-25 can suppress T-cell migration by targeting CXCR3, potentially reducing pancreatic inflammation.
